Changes in diffuse-optical-tomography images during early stages of neoadjuvant chemotherapy correlate with tumor response in different breast cancer subtypes.

CONCLUSIONS: This study demonstrates that DOTBIS measured features change over time according to tumor pCR status and may predict early in the NAC treatment course whether a patient is responding to NAC.
PMID: 33451976 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - January 15, 2021 Category: Cancer & Oncology Authors: Altoe M, Kalinsky K, Marone A, Kim HK, Guo H, Hibshoosh H, Tejada M, Crew KD, Accordino M, Trivedi MS, Hershman DL, Hielscher AH Tags: Clin Cancer Res Source Type: research